This week, we&#39;re talking money! Following the release of BioSpace&#39;s <a href="https://www.biospace.com/article/report-2024-u-s-life-sciences-salary-trends/" target="_blank" rel="noopener noreferer">2024 Salary Report</a>, we discuss salary trends and how they are impacting the biopharma workforce. Considering growth rates, we also discuss asking for <a href="https://www.biospace.com/article/with-the-salary-growth-rate-slowing-should-biopharma-employees-look-for-new-jobs-/" target="_blank" rel="noopener noreferer">raises vs looking for a new job</a> and what salary trends may spell out for the rest of the year. 
 
Guest
<a href="https://www.linkedin.com/in/chantalyeungdresner/" target="_blank" rel="noopener noreferer">Chantal Dresner</a>, VP of Marketing, BioSpace
<a href="https://www.linkedin.com/in/angelagabriel/" target="_blank" rel="noopener noreferer">Angela Gabriel</a>, Content Manager - Careers, BioSpace
 
Host 
<a href="https://www.linkedin.com/in/lorielliskatz/" target="_blank">⁠⁠⁠⁠⁠⁠⁠Lori Ellis⁠⁠⁠⁠⁠⁠⁠</a>, Head of Insights, BioSpace

Bayer’s sweeping executive cuts, Wegovy’s expanding reach

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.